JEFFREY B KINDLER
CIK 1174454 · Executive Chairman · last filed 2026-05-05
JEFFREY B KINDLER is an Executive Chairman who has filed 172 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for TERN, was dated May 5, 2026. Across all open-market trades the lifetime net is −$1.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $24.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$24.59M
10
172
-$1.08M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. (TERN) Delisted | Director | — | $52.95 | — | $0 | 9 | 2026-05-05 |
| PGEN | Director | 202,100 | $4.45 | $899.3K | -$1.71M | 17 | 2026-03-16 |
| PRAX | Director | 688 | $266.58 | $183.4K | $0 | 1 | 2026-02-10 |
| PRGO | Director | 10,559 | $10.99 | $116.0K | -$497.5K | 15 | 2025-05-16 |
| PPD, Inc. (PPD) Delisted | Director | 0 | $47.28 | $0 | $499.5K | 4 | 2021-12-08 |
| VTVT | Executive Chairman | 35,000 | $32.77 | $1.15M | $0 | 7 | 2020-06-15 |
| SIGA | Director | 127,339 | $4.32 | $550.1K | $0 | 10 | 2020-05-22 |
| PRECIGEN, INC. (XON) Delisted | Director | 84,040 | — | — | $627.7K | 16 | 2019-03-26 |
| CMG | Director | 313 | $32.23 | $10.1K | $0 | 2 | 2013-05-17 |
| PFE | Former Chairman & CEO | 827,296 | $26.21 | $21.68M | $0 | 91 | 2010-12-17 |
Recent Filings
172 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-05 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Disp (D) | — | $0 | EDGAR |
| 2026-03-16 | PGEN | Exer (M) | +71,839 | $0 | EDGAR |
| 2026-03-12 | PGEN | Grant (A) | +19,658 | $69.0K | EDGAR |
| 2026-02-10 | PRAX | Grant (A) | +1,166 | $0 | EDGAR |
| 2026-02-02 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-12-16 | PGEN | Sell (S) | −235,467 | -$855.9K | EDGAR |
| 2025-10-01 | PGEN | Sell (S) | −174,360 | -$604.2K | EDGAR |
| 2025-06-12 | Terns Pharmaceuticals, Inc. (TERN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-05-16 | PRGO | Mixed | +5,150 | $134.0K | EDGAR |
| 2025-03-17 | PGEN | Mixed | +127,067 | $69.0K | EDGAR |